TabletAnti Diabetic

Sitagliptin + Metformin

Sitagliptin + Metformin Hydrochloride · DPP-4 inhibitor and biguanide combination

TabletAnti Diabetic

Sitagliptin + MetforminProspero Healthcare

A tablet combining sitagliptin, a DPP-4 inhibitor, with metformin, a biguanide that reduces hepatic glucose output. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sitagliptin + Metformin Hydrochloride
Available strengthsIndicative: 50 mg + 500 mg · 50 mg + 1000 mg
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: DPP-4 inhibitor and biguanide combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category